The largest database of trusted experimental protocols

Millex hv syringe driven filter unit

Manufactured by Merck Group
Sourced in United States

The Millex-HV syringe-driven filter unit is a lab equipment product designed for rapid, sterile filtration of small sample volumes. It features a hydrophilic polyvinylidene fluoride (PVDF) membrane with a pore size of 0.45 μm or 0.22 μm, providing efficient removal of particulates and microorganisms from solutions.

Automatically generated - may contain errors

2 protocols using millex hv syringe driven filter unit

1

Determining Spray-Dried Ketoprofen Yield

Check if the same lab product or an alternative is used in the 5 most similar protocols
The mass ratio of dry powder collected after spray-drying to the initial solid compositions before drying was calculated to determine the percentage yield of each sample. For drug content calculation, a precisely scaled amount of the spray-dried samples was dissolved in 10 mL of distilled 50% methanol and stirred at 400 rpm by a magnetic stirrer (AREC. X heating magnetic stirrer, Velp Scientifica Srl, Italy) at room temperature for 24 h. Then, samples were filtered by filtration disks (0.45 µm pore size, Millex-HV syringe-driven filter unit, Millipore Corporation, Bedford, MA, USA) and quantified spectrophotometrically at λ 258 nm by UV (ATI-Unicam UV/VIS Spectrophotometer, Cambridge, UK). The percentage of ketoprofen content was determined as a ratio of calculated to theoretical drug content.
+ Open protocol
+ Expand
2

Pulmonary Drug Release Evaluation

Check if the same lab product or an alternative is used in the 5 most similar protocols
A modified paddle method (Hanson SR8 Plus, Teledyne Hanson Research, Chatsworth, CA, USA) from European Pharmacopeia was applied to study the release of KETO [102 ]. A 100 mL vessels’ volume instead of 1000 mL was used with smaller paddle size. A simulated lung fluid (SLF), which was composed of NaCl, NaHCO3, CaCl2, NaH2PO4, H2SO4, and glycine (pH = 7.4), was prepared [103 ]. Vessels were filled with 50 mL of SLF, and temperature was set to 37 °C. These parameters were designed based on the human airways’ circumstances [104 (link),105 (link)]. The raw drug and samples equivalent to 5 mg of KETO (based on drug content analysis) were dispersed in the medium. We decided the pulmonary dose of KETO as 10% of its oral dose [60 (link)]. The rotation of paddles was adjusted to 50 rpm, and the duration of the study was 120 min. A total of 2 mL of each sample was withdrawn and replenished after 5, 10, 15, 30, 60, and 120 min. Samples were filtered (filtration disks with 0.45 µm pore size, Millex-HV syringe-driven filter unit, Millipore Corporation, Bedford, MA, USA), and then quantified spectrophotometrically at λ 258 nm (UV/VIS ATI-UNICAM UV/VIS Spectrophotometer, Cambridge, UK). Measurements were carried out in triplicate.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!